美股异动 | 医药板块走高 礼来(LLY.US)涨超1%

Core Viewpoint - The pharmaceutical sector is experiencing a rise, driven by positive developments in drug trials, particularly for Eli Lilly's cancer treatment Verzenio, which has shown significant improvements in overall survival rates for specific breast cancer patients [1] Company Summary - Eli Lilly (LLY.US) shares increased by over 1% following the announcement of breakthrough progress in late-stage clinical trials for its oncology drug Verzenio [1] - UnitedHealth (UNH.US) saw a 0.99% rise, while Molina Health (MOH.US) rose by over 1.9% [1] - Cigna (CI.US) experienced a slight increase of 0.19%, and Novo Nordisk (NVO.US) rose by 0.85% [1] - Johnson & Johnson (JNJ.US) shares increased by 0.58% [1] Industry Summary - The overall pharmaceutical sector is showing positive momentum, with multiple companies in the sector experiencing stock price increases [1] - The announcement regarding Verzenio's clinical trial results highlights the ongoing innovation and potential for growth within the oncology segment of the pharmaceutical industry [1]